Center-Authored Papers

Filters: Author is Liang, Xiaolin  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Reding KW, Bernstein JL, Langholz BM, Bernstein L, Haile RW, Begg CB, Lynch CF, Concannon P, Borg A, Teraoka SN et al..  2010.  Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancer.. Breast cancer research and treatment. 123(2):491-8. Abstract
Setiawan VW, Pike MC, Karageorgi S, Deming SL, Anderson K, Bernstein L, Brinton LA, Cai H, Cerhan JR, Cozen W et al..  2012.  Age at Last Birth in Relation to Risk of Endometrial Cancer: Pooled Analysis in the Epidemiology of Endometrial Cancer Consortium.. American journal of epidemiology. 176(4):269-278. Abstract
Knight JA, Fan J, Malone KE, John EM, Lynch CF, Langballe R, Bernstein L, Shore RE, Brooks JD, Reiner AS et al..  2017.  Alcohol consumption and cigarette smoking in combination: A predictor of contralateral breast cancer risk in the WECARE study.. International journal of cancer. Abstract
Knight JA, Bernstein L, Largent J, Capanu M, Begg CB, Mellemkjaer L, Lynch CF, Malone KE, Reiner AS, Liang X et al..  2009.  Alcohol intake and cigarette smoking and risk of a contralateral breast cancer: The Women's Environmental Cancer and Radiation Epidemiology Study.. American journal of epidemiology. 169(8):962-8. Abstract
Capanu M, Concannon P, Haile RW, Bernstein L, Malone KE, Lynch CF, Liang X, Teraoka SN, Diep AT, Thomas DC et al..  2011.  Assessment of rare BRCA1 and BRCA2 variants of unknown significance using hierarchical modeling.. Genetic epidemiology. 35(5):389-97. Abstract
Robson ME, Reiner AS, Brooks JD, Concannon PJ, John EM, Mellemkjaer L, Bernstein L, Malone KE, Knight JA, Lynch CF et al..  2017.  Association of Common Genetic Variants With Contralateral Breast Cancer Risk in the WECARE Study.. Journal of the National Cancer Institute. 109(10) Abstract
B
Prescott J, Setiawan VW, Wentzensen N, Schumacher F, Yu H, Delahanty R, Bernstein L, Chanock SJ, Chen C, Cook LS et al..  2015.  Body Mass Index Genetic Risk Score and Endometrial Cancer Risk.. PloS one. 10(11):e0143256. Abstract
Brooks JD, John EM, Mellemkjaer L, Lynch CF, Knight JA, Malone KE, Reiner AS, Bernstein L, Liang X, Shore RE et al..  2016.  Body mass index, weight change, and risk of second primary breast cancer in the WECARE study: influence of estrogen receptor status of the first breast cancer.. Cancer medicine. 5(11):3282-3291. Abstract
C
Borg A, Haile RW, Malone KE, Capanu M, Diep A, Törngren T, Teraoka S, Begg CB, Thomas DC, Concannon P et al..  2010.  Characterization of BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance in unilateral and bilateral breast cancer: the WECARE study.. Human mutation. 31(3):E1200-40. Abstract
Machiela MJ, Zhou W, Sampson JN, Dean MC, Jacobs KB, Black A, Brinton LA, Chang I-S, Chen C, Chen C et al..  2015.  Characterization of large structural genetic mosaicism in human autosomes.. American journal of human genetics. 96(3):487-97. Abstract
Bernstein JL, Thomas DC, Shore RE, Robson M, Boice JD, Stovall M, Andersson M, Bernstein L, Malone KE, Reiner AS et al..  2013.  Contralateral breast cancer after radiotherapy among BRCA1 and BRCA2 mutation carriers: A WECARE Study Report.. European journal of cancer (Oxford, England : 1990). 49(14):2979-2985. Abstract
E
Chen MM, Crous-Bou M, Setiawan VW, Prescott J, Olson SH, Wentzensen N, Black A, Brinton L, Chen C, Chen C et al..  2014.  Exome-wide association study of endometrial cancer in a multiethnic population.. PloS one. 9(5):e97045. Abstract
F
Machiela MJ, Zhou W, Karlins E, Sampson JN, Freedman ND, Yang Q, Hicks B, Dagnall C, Hautman C, Jacobs KB et al..  2016.  Female chromosome X mosaicism is age-related and preferentially affects the inactivated X chromosome.. Nature communications. 7:11843. Abstract
G
De Vivo I, Prescott J, Setiawan VW, Olson SH, Wentzensen N, Attia J, Black A, Brinton L, Chen C, Chen C et al..  2014.  Genome-wide association study of endometrial cancer in E2C2.. Human genetics. 133(2):211-24. Abstract
Chen MM, O'Mara TA, Thompson DJ, Painter JN, Attia J, Black A, Brinton L, Chanock S, Chen C, Cheng TH et al..  2016.  GWAS meta-analysis of 16,852 women identifies new susceptibility locus for endometrial cancer.. Human molecular genetics. Abstract
H
Reiner AS, Lynch CF, Sisti JS, John EM, Brooks JD, Bernstein L, Knight JA, Hsu L, Concannon P, Mellemkjær L et al..  2017.  Hormone receptor status of a first primary breast cancer predicts contralateral breast cancer risk in the WECARE study population.. Breast cancer research : BCR. 19(1):83. Abstract
I
Felix AS, Gaudet MM, La Vecchia C, Nagle CM, Shu XO, Weiderpass E, Adami HO, Beresford S, Bernstein L, Chen C et al..  2015.  Intrauterine devices and endometrial cancer risk: a pooled analysis of the Epidemiology of Endometrial Cancer Consortium.. International journal of cancer. 136(5):E410-22. Abstract
O
Lurie G, Gaudet MM, Spurdle AB, Carney ME, Wilkens LR, Yang HP, Weiss NS, Webb PM, Thompson PJ, Terada K et al..  2011.  The obesity-associated polymorphisms FTO rs9939609 and MC4R rs17782313 and endometrial cancer risk in non-Hispanic white women.. PloS one. 6(2):e16756. Abstract
R
Bernstein JL, Haile RW, Stovall M, Boice JD, Shore RE, Langholz B, Thomas DC, Bernstein L, Lynch CF, Olsen JH et al..  2010.  Radiation exposure, the ATM Gene, and contralateral breast cancer in the women's environmental cancer and radiation epidemiology study.. Journal of the National Cancer Institute. 102(7):475-83. Abstract
Sisti JS, Bernstein JL, Lynch CF, Reiner AS, Mellemkjaer L, Brooks JD, Knight JA, Bernstein L, Malone KE, Woods M et al..  2015.  Reproductive factors, tumor estrogen receptor status and contralateral breast cancer risk: results from the WECARE study.. SpringerPlus. 4:825. Abstract
Cote ML, Alhajj T, Ruterbusch JJ, Bernstein L, Brinton LA, Blot WJ, Chen C, Gass M, Gaussoin S, Henderson B et al..  2015.  Risk factors for endometrial cancer in black and white women: a pooled analysis from the Epidemiology of Endometrial Cancer Consortium (E2C2).. Cancer causes & control : CCC. 26(2):287-96. Abstract
S
Teraoka SN, Bernstein JL, Reiner AS, Haile RW, Bernstein L, Lynch CF, Malone KE, Stovall M, Capanu M, Liang X et al..  2011.  Single nucleotide polymorphisms associated with risk for contralateral breast cancer in the Women's Environment, Cancer and Radiation Epidemiology (WECARE) study.. Breast cancer research : BCR. 13(6):R114. Abstract
Langballe R, Mellemkjær L, Malone KE, Lynch CF, John EM, Knight JA, Bernstein L, Brooks J, Andersson M, Reiner AS et al..  2016.  Systemic therapy for breast cancer and risk of subsequent contralateral breast cancer in the WECARE Study.. Breast cancer research : BCR. 18(1):65. Abstract
T
Setiawan VW, Doherty JA, Shu X-O, Akbari MR, Chen C, De Vivo I, Demichele A, Garcia-Closas M, Goodman MT, Haiman CA et al..  2009.  Two estrogen-related variants in CYP19A1 and endometrial cancer risk: a pooled analysis in the Epidemiology of Endometrial Cancer Consortium.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 18(1):242-7. Abstract
Setiawan VW, Yang HP, Pike MC, McCann SE, Yu H, Xiang Y-B, Wolk A, Wentzensen N, Weiss NS, Webb PM et al..  2013.  Type I and II Endometrial Cancers: Have They Different Risk Factors? Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 31(20):2607-18. Abstract